Antibiotic resistance has presented a major health challenge in the world and many isolates of Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa become resistant to almost all current antibiotics. This chapter provides an overview on the mechanisms of antibiotic resistance in these Gram-negative pathogens and outlines the formidable problem of the genetics of bacterial resistance. Prevalent multidrug-resistance in Gram-negative bacteria underscores the need for optimizing the clinical use of the last-line polymyxins
Acinetobacter baumannii, a Gram-negative bacterium, is a notorious nosocomial pathogen. It is innate...
Antibiotic resistance is an escalating problem, not only due to less desirable treatment options and...
The emergence of antimicrobial drug resistance is of enormous public concern due to the increased ri...
International audiencePolymyxins are polycationic antimicrobial peptides that are currently the last...
The global rise in antibiotic resistance in bacteria poses a major challenge in treating infectious ...
Humanity is facing an enormous and growing worldwide threat from the emergence of multi-drug-resista...
Since the discovery and subsequent widespread use of antibiotics, a variety of bacterial species of ...
Antibiotic resistance has increased markedly in gram-negative bacteria over the last two decades, an...
Pseudomonas aeruginosa, a gram-negative bacillus, is a multidrug resistant (MDR) pathogen posing a t...
Polymyxins are old designed antibiotics that have recently regained significant interest as a conseq...
Nosocomial antibiotic resistance is an increasing problem world wide; some pathogens, particularly P...
Clinical “superbug ” isolates of Pseudomonas aeruginosa were previously observed to be resistant to ...
Multidrug-resistant Gram-negative bacterial infections are exponentially increasing, posing one of t...
Polymyxins are often last-line therapeutic agents used to treat infections caused by multidrug-resis...
In the last decade, we have witnessed a dramatic increase in the number of multidrug resistant Gram-...
Acinetobacter baumannii, a Gram-negative bacterium, is a notorious nosocomial pathogen. It is innate...
Antibiotic resistance is an escalating problem, not only due to less desirable treatment options and...
The emergence of antimicrobial drug resistance is of enormous public concern due to the increased ri...
International audiencePolymyxins are polycationic antimicrobial peptides that are currently the last...
The global rise in antibiotic resistance in bacteria poses a major challenge in treating infectious ...
Humanity is facing an enormous and growing worldwide threat from the emergence of multi-drug-resista...
Since the discovery and subsequent widespread use of antibiotics, a variety of bacterial species of ...
Antibiotic resistance has increased markedly in gram-negative bacteria over the last two decades, an...
Pseudomonas aeruginosa, a gram-negative bacillus, is a multidrug resistant (MDR) pathogen posing a t...
Polymyxins are old designed antibiotics that have recently regained significant interest as a conseq...
Nosocomial antibiotic resistance is an increasing problem world wide; some pathogens, particularly P...
Clinical “superbug ” isolates of Pseudomonas aeruginosa were previously observed to be resistant to ...
Multidrug-resistant Gram-negative bacterial infections are exponentially increasing, posing one of t...
Polymyxins are often last-line therapeutic agents used to treat infections caused by multidrug-resis...
In the last decade, we have witnessed a dramatic increase in the number of multidrug resistant Gram-...
Acinetobacter baumannii, a Gram-negative bacterium, is a notorious nosocomial pathogen. It is innate...
Antibiotic resistance is an escalating problem, not only due to less desirable treatment options and...
The emergence of antimicrobial drug resistance is of enormous public concern due to the increased ri...